Cationic polymer carriers have shown promise in non-viral gene delivery but face challenges such as low transfection efficiency and high toxicity. To address these issues, we synthesized a novel biodegradable poly(amidoamine) (PAA) cationic polymer, 4-(4-biguanide benzoylamino)butylamine-N,N’-bis(acryloyl)cystamine (PDAB-CBA). This polymer incorporates bis(guanidinium) groups and a hydrophobic benzene ring to enhance membrane affinity and hydrophobic interactions, respectively, thereby improving gene delivery performance. The inclusion of disulfide bonds in the polymer’s backbone imparts reductive response properties, allowing for degradation into small molecular weight fragments within cellular environments and reducing cytotoxicity. Our studies demonstrated that PDAB-CBA formed stable, uniform nanoparticles with plasmid DNA (pDNA), achieving an encapsulation efficiency of approximately 85% at a 6:1 weight ratio. The polyplexes had the average particle size of around 100 nm and the zeta potential between 25-35 mV, ensuring effective cellular uptake. PDAB-CBA/pDNA polyplexes exhibited higher transfection efficiency, with relative light units (RLU) greater than 1 × 105 at weight ratios of 6:1 to 24:1, compared to PEI/pDNA. Furthermore, PDAB-CBA demonstrated low cytotoxicity, maintaining cell viability above 80% at weight ratios below 24:1, and effectively protected genes against DNaseI degradation and heparin replacement. The primary endocytosis pathway for these polyplexes was clathrin-mediated endocytosis. Overall, PDAB-CBA exhibited superior gene delivery capabilities and a favorable safety profile, providing a new strategy for the design of efficient and low-toxicity gene delivery vectors.
Read full abstract